FDA Approves Nivolumab Plus Cabozantinib for Advanced RCC
FDA Approves Nivolumab Plus Cabozantinib for Advanced RCC
Jan 22, 2021
onclive.com
MONJUVI MOA
16:43
MONJUVI MOA
Aug 6, 2020
monjuvihcp.com
FDA Approves First-Line Nivolumab for Advanced Melanoma | OncLive
FDA Approves First-Line Nivolumab for Advanced Melanoma | OncLive
Nov 24, 2015
onclive.com
Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma | OncLive
Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma | OncLive
3 weeks ago
onclive.com
#ESMO20: Watch Toni Choueiri reporting on key results from the ESMO Virtual Congress 2020 on nivolumab cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: first results from the randomised phase 3 CheckMate 9ER trial. 👉 More ESMO Video Highlights: http://ow.ly/aNZj50BAVXA | ESMO - European Society for Medical Oncology
2:05
#ESMO20: Watch Toni Choueiri reporting on key results from the …
2K viewsSep 26, 2020
FacebookESMO - European Society for Medical Oncology
Nivolumab (Opdivo) Approved in Japan for the Treatment of Advanced Melanoma | AJMC
Nivolumab (Opdivo) Approved in Japan for the Treatment of Advan…
1 week ago
ajmc.com
Immunotherapeutic Use Expanded to Head and Neck Cancer
Immunotherapeutic Use Expanded to Head and Neck Cancer
Feb 4, 2020
aacr.org
Five-Year Outcomes With First-Line (1L) Nivolumab Ipilimumab Chemo…
Jun 17, 2024
onclive.com
2:28
In patients with advanced Hodgkin’s lymphoma, adding brentuximab v…
1.8K views1 year ago
FacebookThe New England Journal of Medicine
Dr Awad on the FDA Approval of Perioperative Nivolumab for Rese…
Oct 3, 2024
onclive.com
CheckMate 816: Neoadjuvant Nivolumab Plus Chemotherapy Bo…
Oct 5, 2021
ascopost.com
An Introduction to Front-line Nivolumab/Ipilimumab Therapy fo…
9 months ago
targetedonc.com
Nivolumab plus Ipilimumab for Frontline Treatment of Advanced …
2 weeks ago
onclive.com
Initial Efficacy and Safety of RP1 + Nivolumab in Patients With Anti–P…
2 weeks ago
onclive.com
CheckMate-214 at 8 Years: Nivolumab + Ipilimumab Shows D…
Mar 5, 2024
urotoday.com
4:45
Treating Melanoma
58.3K viewsJul 22, 2020
YouTubeYou and Melanoma
ESMO 2020 Highlights on nivolumab+cabozantinib as 1st lin…
2.3K viewsSep 19, 2020
YouTubeEuropean Society for Medical Oncology (ESMO)
2:23
Perioperative Nivolumab in Resectable NSCLC | NEJM
1.7K viewsMay 16, 2024
YouTubeNEJM Group
4:57
Omvoh (mirikizumab) for Ulcerative Colitis: US FDA Approved Treatm…
1.5K viewsAug 31, 2024
YouTubeMr. Lightyear
Novel Agents for Multiple Myeloma
Apr 28, 2017
onclive.com
WHAT IS NIVOLUMAB (OPTIVO)? [VLOG 21]
1.1K viewsJun 24, 2018
YouTubeJah D
Highlights on 1L nivolumab + chemo for metastatic urothelial carcinom…
1.2K viewsOct 23, 2023
YouTubeEuropean Society for Medical Oncology (ESMO)
Lobar vs. Sublobar Resection for Peripheral Stage IA NSCLC | NEJM
2K viewsFeb 9, 2023
YouTubeNEJM Group
3:11
Nivolumab for perioperative esophageal and gastroesophagea…
1.4K viewsSep 29, 2020
YouTubeVJOncology
1:21:35
Immunotherapy 2023/2024
8K viewsJul 8, 2023
YouTubeStanley Kim
10:45
The CheckMate 9LA Trial for Stage IV/Recurrent Non-Small Cell Lung …
1.1K viewsJun 22, 2020
YouTubeOncLive
RELATIVITY-047: relatlimab, an anti-LAG-3 antibody + nivolumab in fir…
2.6K viewsJun 6, 2021
YouTubeVJOncology
#ESMO21 Highlights on nivolumab in pretreated thymoma & thymic c…
1.5K viewsSep 18, 2021
YouTubeEuropean Society for Medical Oncology (ESMO)
Dr. Kluger on a Phase I Trial of Concurrent Nivolumab and Ipilimu…
Sep 28, 2014
onclive.com
42:48
Immunotherapy for Lung Cancer
14.7K viewsJan 18, 2016
YouTubeGlobal Resource for Advancing Cancer Education
See more videos
Static thumbnail place holder